NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer combo shows promise but study ends early
Disease control TerminatedThis study tested whether adding a single dose of radiation to the immunotherapy drug atezolizumab could help people with advanced lung cancer whose disease had worsened after chemotherapy and another immunotherapy. The trial planned to enroll 12 adults with stage IV non-small ce…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lung cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a potent chemotherapy directly to cancer cells. …
Matched conditions: NSCLC STAGE IV
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:02 UTC